Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Voltage-gated calcium channels (VGCCs) in cestodes are essential membrane proteins that regulate the influx of calcium ions, which is vital for neuromuscular coordination and the maintenance of the parasite's tegumental integrity. The beta subunit (Cavβ) of these channels has been identified as the specific molecular target for praziquantel, the primary anthelmintic used to treat tapeworm infections such as taeniasis and neurocysticercosis (Park & Marchant, 2012). When praziquantel binds to the Cavβ subunit, it induces a rapid and sustained influx of calcium into the parasite's syncytial tegument and musculature (Kohn et al., 2001). This influx causes immediate tetanic contraction, leading to paralysis and the formation of vacuoles on the parasite's surface, which eventually rupture. The destruction of the tegument exposes the parasite to the host's immune system and digestive enzymes, facilitating its elimination (Greenberg, 2005). Because these channels are fundamental to the parasite's survival, they represent a high-value target for drug development, although the inflammatory response to dying parasites in the host's central nervous system remains a significant clinical challenge (White, 2014).
Praziquantel acts as an allosteric modulator of the voltage-gated calcium channel beta subunit, inducing a rapid influx of calcium ions into the parasite's cells, resulting in tetanic contraction and tegumental damage.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-gated calcium channel subunit beta (Cavβ) (Cavβ).